1382P Phase Ib/II open-label, randomised evaluation of second-line atezolizumab (atezo) + linagliptin (lina) vs ramucirumab (ram) + paclitaxel (pac) in MORPHEUS-gastric cancer
| Autor: | Lee, J. 1, Ajani, J.A. 2, Chung, H.C. 3, Kang, Y-K. 4, Iqbal, S. 5, Allen, S. 6, Al-Sakaff, N. 7, Decalf, J. 8, Li, S. 9, Pintoffl, J. 7, Sayyed, P. 7, Bang, Y-J. 10 |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S1047-S1047 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|